Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Agamatrix, Inc. · Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

115 daysmedian FDA review time
370 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K161834One Drop Blood Glucose Monitoring SystemAgamatrix, Inc.2016-11-301480
K152365AgaMatrix Jazz Wireless 2 Blood Glucose Monitoring SystemAgamatrix, Inc.2016-04-212440
K132821AGAMATRIX HEALTH MANAGERAgamatrix, Inc.2013-11-20720
K130535IBGSTAR BLOOD GLUCOSE MONITORING SYSTEM, IBGSTAR DIABETES MAAgamatrix, Inc.2013-04-17470
K103544IBGSTAR BLOOD GLUCOSE MONITORING SYSTEM, IBGSTAR DIABETES MAAgamatrix, Inc.2011-12-073700
K083265JAZZ WIRELESS BLOOD GLUCOSE MONITORING SYSTEM, MODEL 8000-03Agamatrix, Inc.2009-02-03900
K052762LIBERTY BLOOD GLUCOSE MONITORING SYSTEM, MODEL 8000-0067Agamatrix, Inc.2006-01-231150

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda